Aiming at excellence in adopting and using drug generic names
- At: 2005 FIP Congress in Cairo (Egypt)
- Type: Poster
- By: VIDOTTI, Carlos (Federal Council of Pharmacy, Brazilian Medicines Information Center, Brasilia, Brazil)
- Co-author(s): Moraes (ANVISA/MS, BRASILIA, Brazil)
Introduction: Drugs are identified by many names and codes, according to their developing status and use. This causes confusion over the pharmaceutical chain, including harm to users of drugs and loss of money due to market of a same drug with different names. Considering this situation, Brazilian authorities have adopted regulations to harmonize.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.